Finance

Beta
Lists
ANIP:NASDAQ
ANI Pharmaceuticals Inc Common Stock
$81.20
+1.34%
(+1.07) 1D
$81.20
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIP...
Open
$81.05
High
$82.25
Low
$80.76
Mkt. cap
1.85B
Avg. vol.
377.42K
Volume
271.95K
P/E ratio
20.71
52-wk high
$99.50
52-wk low
$61.35
EPS
$3.92
Beta
0.44
Shares outstanding
22.74M
No. of employees
970
Open
$81.05
High
$82.25
Low
$80.76
Mkt. cap
1.85B
Avg. vol.
377.42K
Volume
271.95K
P/E ratio
20.71
52-wk high
$99.50
52-wk low
$61.35
EPS
$3.92
Beta
0.44
Shares outstanding
22.74M
No. of employees
970
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to ANIP in the past 3 months
Strong Buy
Buy
6
Hold
1
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ANIP in the last 3 months.
Highest
Current $81.20
$124.00 (+52.71%)
Average
$115.20 (+41.87%)
Lowest
$100.00 (+23.15%)
News stories
From sources across the web
About ANI Pharmaceuticals Inc Common Stock
CEO-
Employees970
Founded2001
HeadquartersBaudette, Minnesota, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
211.37M
227.81M
247.06M
237.46M
Cost of goods sold
74.62M
93.39M
100.27M
93.58M
Cost of revenue
74.62M
93.39M
100.27M
93.58M
Research and development expenses
16.54M
12.30M
12.26M
10.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
81.57M
76.26M
82.29M
73.66M
Operating expense
121.39M
111.19M
117.16M
105.17M
Total operating expenses
196.00M
204.58M
217.43M
198.76M
Operating income
15.37M
23.23M
29.63M
38.71M
Other non operating income
-
-
-
-
EBT including unusual items
10.52M
33.80M
31.48M
40.22M
EBT excluding unusual items
11.67M
17.65M
26.07M
34.29M
Income tax expense
1.98M
7.18M
3.99M
10.73M
Effective tax rate
18.77%
21.25%
12.67%
26.68%
Other operating expenses
-
-
-
-
Net income
8.55M
26.62M
27.49M
29.49M
Net profit margin
4.04%
11.68%
11.13%
12.42%
Earnings per share
1.80
2.04
2.33
2.05
Interest and investment income
2.70M
3.55M
3.16M
3.78M
Interest expense
-8.13M
-8.28M
-7.57M
-7.55M
Net interest expenses
-5.44M
-4.73M
-4.41M
-3.77M
Depreciation and amortization charges
23.28M
22.63M
22.61M
20.92M
EBITDA
38.65M
45.86M
52.24M
59.62M
Gain or loss from assets sale
-
295.00K
87.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more